Mitochondrial respiratory chain dysfunction variably increases oxidant stress in Caenorhabditis elegans.
Mitochondrial dysfunction and associated oxidant stress have been linked with numerous complex diseases and aging largely by in vitro determination of mitochondria oxidant production and scavenging. We applied targeted in vivo fluorescence analyses of mitochondria-dense pharyngeal tissue in Caenorhabditis elegans to better understand relative mitochondrial effects, particularly on matrix oxidant burden, of respiratory chain complex, MnSOD, and insulin receptor mutants displaying variable longevity. The data demonstrate significantly elevated in vivo matrix oxidant burden in the short-lived complex I mutant, gas-1(fc21), which was associated with limited superoxide scavenging capacity despite robust MnSOD induction, as well as decreased mitochondria content and membrane potential. Significantly increased MnSOD activity was associated with in vivo matrix oxidant levels similar to wild-type in the long-lived respiratory chain complex III mutant, isp-1(qm150). Yet, despite greater superoxide scavenging capacity in the complex III mutant than in the significantly longer-lived insulin receptor mutant, daf-2(e1368), only the former showed modest oxidative stress sensitivity. Furthermore, increased longevity was seen in MnSOD knockout mutants (sod-2(ok1030) and sod-2(gk257)) that had decreased MnSOD scavenging capacity and increased in vivo matrix oxidant burden. Thus, factors beside oxidant stress must underlie RC mutant longevity in C. elegans. This work highlights the utility of the C. elegans model as a tractable means to non-invasively monitor multi-dimensional in vivo consequences of primary mitochondrial dysfunction.
Dingley
Stephen
S
Division of Human Genetics, Department of Pediatrics, The Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA 19104, USA. stephen.dingley@gmail.com <stephen.dingley@gmail.com>
Polyak
Erzsebet
E
Lightfoot
Richard
R
Ostrovsky
Julian
J
Rao
Meera
M
Greco
Todd
T
Ischiropoulos
Harry
H
Falk
Marni J
MJ
D000818:Animals; D017173:Caenorhabditis elegans / Q000235:genetics / Q000502:physiology*; D029742:Caenorhabditis elegans Proteins; D004579:Electron Transport; D014450:Electron Transport Complex III / Q000172:deficiency; D008136:Longevity; D053078:Membrane Potential, Mitochondrial; D008928:Mitochondria / Q000502:physiology*; D009245:NADH Dehydrogenase / Q000172:deficiency; D016877:Oxidants / Q000633:toxicity*; D018384:Oxidative Stress; D011972:Receptor, Insulin / Q000172:deficiency; D013482:Superoxide Dismutase / Q000172:deficiency; D000099156:Superoxide Dismutase 2
D029742:Caenorhabditis elegans Proteins; D014450:Electron Transport Complex III; D009245:NADH Dehydrogenase; D016877:Oxidants; D011972:Receptor, Insulin; D013482:Superoxide Dismutase; D000099156:Superoxide Dismutase 2; C443102:Isp-1 protein, Caenorhabditis elegans; C107483:DAF-2 protein, C elegans; C468009:GAS-1 protein, C elegans